Bradley Messmer
Principal investigator, leads ABREOS BIOSCIENCES, INC..
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$2.4MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Apr 1, 2018 | NIH | SBIR Phase I Affinity Purification of Biologics with Mimetope Peptides | $218K | ABREOS BIOSCIENCES, INC. |
| Sep 5, 2017 | NIH | SBIR Phase II Personalized precision dosing of biologic therapies in oncology | $1.5M | ABREOS BIOSCIENCES, INC. |
| Sep 25, 2015 | NIH | SBIR Phase I Activin A antagonist for treatment of cancer-associated cachexia | $225K | ABREOS BIOSCIENCES, INC. |
| Mar 1, 2015 | NIH | SBIR Phase I Cleavage Coupled Lateral Flow Immunoassay for Rapid Endotoxin Testing | $214K | ABREOS BIOSCIENCES, INC. |
| 2015 | NIH | SBIR Phase I Multiplexed DeNAno Protein Assay and Quantitation: Sequencing Based Proteomics | $225K | ABREOS BIOSCIENCES, INC. |
Peer ranks
Federal funding#916
Awards as PI#470
Patents#505
Companies
- ABREOS BIOSCIENCES, INC.Leads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.